EVOLVİNG PARADİGMS İN THE MANAGEMENT OF PRİMARY IMMUNE THROMBOCYTOPENİA İN ADULTS: FROM CORTİCOSTEROİDS TO TARGETED BİOLOGİC THERAPİES. Mediterr J Hematol Infect Dis [Internet]. 2026 Sep. 1 [cited 2026 Sep. 2];18(1):e2026067. Available from: https://www.mjhid.org/mjhid/article/view/6450